Home East Africa Museveni inaugurates Dei Biopharma manufacturing facility

Museveni inaugurates Dei Biopharma manufacturing facility

204
  • Dei Biopharma manufacturing facility was commissioned by the President of Uganda Yoweri Kaguta Museveni in Matugga, near Kampala. Incorporated in Uganda, in January 2014 Dei BioPharma Uganda Ltd is a medical and foods (nutraceuticals & pharmaceutical) research company.

Dei Biopharma manufacturing facility was commissioned by the President of Uganda Yoweri Kaguta Museveni in Matugga, near Kampala. Incorporated in Uganda, in January 2014 Dei BioPharma Uganda Ltd is a medical and foods (nutraceuticals & pharmaceutical) research company. The company manufacture medicines, food supplements and cosmetics.

The commencement of the operations of the plant is expected to facilitate the supply of high-quality and affordable medicines of therapeutic medications including cancer and malaria treatment across Africa.

Speaking on the occasion, Dei Group Managing Director, Mathias Magoola said that with the commissioning of the new plant, the company has entered a new phase. He added that the facility is proof of Uganda’s scientific innovation and will produce biological solutions listed as essential drugs, including Filgrastim, Erythropoietin, and Trastuzumab among others. He disclosed that Dei BioPharma has secured more than 3,000 formulations and is capable of producing a wide range of potential drugs, vaccines, anti-cancer drugs, therapeutic proteins, peptides and cell therapy, and so on.

The facility has been financed through partner funding from the Equity Group amounting to US$100 million for construction, importation of Hi-Tech Medical Equipment and machines as well as working capital support. The Uganda Development Bank has contributed US$20 million.

According to sources, the facility is the only African pharmaceutical company now manufacturing Covid-19 therapeutic medications. The company is getting ready to produce one billion doses of mRNA vaccines guided by World Health Organization, WHO standards. In March 2022, a team of experts from the WHO applauded Dei Biopharma for establishing the manufacturing facility, setting up a base for Africa to effectively respond to Covid-19 and other viruses using both traditional and modern medicinal therapies.

Also read;

https://trendsnafrica.com/ugandan-goods-trading-more-outside-eac/

https://trendsnafrica.com/uganda-to-lift-restrictions-on-iranian-medicine-and-medical-equipment/

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments